We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$5.51B
AUM Growth
+$241M
Cap. Flow
-$117M
Cap. Flow %
-2.12%
Top 10 Hldgs %
34.2%
Holding
110
New
6
Increased
38
Reduced
37
Closed
9

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$84.8M
2
INTC icon
Intel
INTC
+$25.1M
3
MGA icon
Magna International
MGA
+$20.4M
4
MRNA icon
Moderna
MRNA
+$18M
5
LULU icon
lululemon athletica
LULU
+$16.8M

Sector Composition

Rank Sector Weight
1 Financials 32.74%
2 Communication Services 17.71%
3 Materials 12.83%
4 Healthcare 9.73%
5 Technology 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YTRA icon
76
Yatra Online
YTRA
$72.3M
$2.68M 0.05%
1,574,120
SCHW
77
Charles Schwab
SCHW
$186B
$1.42M 0.03%
21,846
URTH icon
78
iShares MSCI World ETF
URTH
$8.19B
$1.16M 0.02%
7,400
SPY icon
79
State Street SPDR S&P 500 ETF Trust
SPY
$803B
$987K 0.02%
1,720
ING icon
80
ING
ING
$105B
$900K 0.02%
49,551
VTWO icon
81
Vanguard Russell 2000 ETF
VTWO
$16.9B
$626K 0.01%
7,000
PBA icon
82
Pembina Pipeline
PBA
$27.8B
$490K 0.01%
11,882
DUK icon
83
Duke Energy
DUK
$93.1B
$473K 0.01%
4,100
+931
+29% +$104K
KMB icon
84
Kimberly-Clark
KMB
$33B
$430K 0.01%
3,025
VALE icon
85
Vale
VALE
$62.2B
$428K 0.01%
36,650
+4,775
+15% +$51.2K
VT icon
86
Vanguard Total World Stock ETF
VT
$81B
$389K 0.01%
3,250
FTS icon
87
Fortis
FTS
$27.8B
$387K 0.01%
8,500
-212,428
-96% -$9.08M
SPRY icon
88
ARS Pharmaceuticals
SPRY
$473M
$358K 0.01%
24,700
DNLI icon
89
Denali Therapeutics
DNLI
$3.37B
$331K 0.01%
11,350
MSFT icon
90
Microsoft
MSFT
$3.75T
$275K 0.01%
638
MET icon
91
MetLife
MET
$61.7B
$239K ﹤0.01%
2,900
ALB icon
92
Albemarle
ALB
$13.9B
$234K ﹤0.01%
+2,475
New +$220K
ALTM
93
DELISTED
Arcadium Lithium plc
ALTM
$209K ﹤0.01%
73,250
+14,750
+25% +$42.7K
MGTX icon
94
MeiraGTx Holdings
MGTX
$1.23B
$189K ﹤0.01%
45,300
AURA icon
95
Aura Biosciences
AURA
$725M
$189K ﹤0.01%
21,200
MLYS icon
96
Mineralys Therapeutics
MLYS
$2.56B
$138K ﹤0.01%
11,400
PLRX icon
97
Pliant Therapeutics
PLRX
$72.4M
$117K ﹤0.01%
+10,400
New +$130K
TCRX icon
98
TScan Therapeutics
TCRX
$21.7M
$103K ﹤0.01%
20,700
ETNB
99
DELISTED
89bio
ETNB
$79.2K ﹤0.01%
+10,700
New +$90K
PROK icon
100
ProKidney
PROK
$376M
$30.5K ﹤0.01%
15,900

Similar funds

Letko, Brosseau & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Letko, Brosseau & Associates held 110 positions worth $5.51B, up 4.6% from $5.27B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Letko, Brosseau & Associates's Q3 2024 filing shows 6 new, 38 increased, 37 reduced and 9 closed positions. Its largest new stake was Illumina: 687,705 shares worth $89.7M. The largest sale was Canadian Natural Resources, an estimated $55.2M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 31% a quarter earlier, followed by Communication Services and Materials.

  • Letko, Brosseau & Associates's largest Q3 2024 buy was Illumina: 687,705 shares worth $89.7M.
  • Letko, Brosseau & Associates added most to Intel in Q3 2024, an estimated $25.1M increase.
  • Letko, Brosseau & Associates's biggest Q3 2024 reduction was Canadian Natural Resources, cutting an estimated $55.2M.
  • Letko, Brosseau & Associates fully exited Fidelity National Information Services in Q3 2024, selling an estimated $42M.
  • Letko, Brosseau & Associates's ten largest holdings make up 34% of its $5.51B portfolio in Q3 2024.
  • Letko, Brosseau & Associates opened 6 new positions and closed 9 in Q3 2024.
  • Letko, Brosseau & Associates's portfolio value rose 4.6% quarter-over-quarter to $5.51B.

Based on Letko, Brosseau & Associates's 13F filing for Q3 2024, filed 7 Nov 2024.